Finance

Lists
Why is 2367 down 2,67%?
Dive Deeper
2367:HKG
Giant Biogene Holding Co Ltd
HK$22,60
-2,67%
(-0,62) 1D
16 Okt., 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2367...
Open
HK$23,22
High
HK$23,48
Low
HK$22,60
Mkt. cap
23,99 mjd
Avg. vol.
2,54 m
Volume
5,03 m
Dividend
2,74%
Quarterly dividend
HK$0,15
Ex-dividend date
01 Jun. 2026
P/E ratio
12,23
52-wk high
HK$45,20
52-wk low
HK$22,40
EPS
HK$1,85
Shares outstanding
1,06 mjd
No. of employees
2 k
Open
HK$23,22
High
HK$23,48
Low
HK$22,60
Mkt. cap
23,99 mjd
Avg. vol.
2,54 m
Volume
5,03 m
Dividend
2,74%
Quarterly dividend
HK$0,15
Ex-dividend date
01 Jun. 2026
P/E ratio
12,23
52-wk high
HK$45,20
52-wk low
HK$22,40
EPS
HK$1,85
Shares outstanding
1,06 mjd
No. of employees
2 k
News stories
From web sources and news partners
About Giant Biogene Holding Co Ltd
CEO-
Employees2,32 k
Founded2000
Headquarters-
SectorPersonal care products
Websitexajuzi.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,20 mjd
1,20 mjd
1,46 mjd
1,46 mjd
Cost of goods sold
257,42 m
257,42 m
299,64 m
299,64 m
Cost of revenue
257,42 m
257,42 m
299,64 m
299,64 m
Research and development expenses
23,81 m
23,81 m
22,76 m
22,76 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
541,58 m
541,58 m
673,36 m
673,36 m
Operating expense
565,15 m
565,15 m
687,61 m
687,61 m
Total operating expenses
822,57 m
822,57 m
987,25 m
987,25 m
Operating income
380,35 m
380,35 m
471,59 m
471,59 m
Other non operating income
-1,55 m
-1,55 m
12,66 m
12,66 m
EBT including unusual items
453,08 m
453,08 m
547,48 m
547,48 m
EBT excluding unusual items
428,11 m
428,11 m
547,48 m
547,48 m
Income tax expense
86,97 m
86,97 m
77,71 m
77,71 m
Effective tax rate
19,20%
19,20%
14,19%
14,19%
Other operating expenses
-
-
-8,51 m
-8,51 m
Net income
366,38 m
366,38 m
469,86 m
469,86 m
Net profit margin
30,46%
30,46%
32,21%
32,21%
Earnings per share
-
-
-
-
Interest and investment income
52,14 m
52,14 m
58,40 m
58,40 m
Interest expense
-89,00 k
-89,00 k
-87,50 k
-87,50 k
Net interest expenses
52,05 m
52,05 m
58,31 m
58,31 m
Depreciation and amortization charges
-
-
-
-
EBITDA
400,13 m
400,13 m
492,01 m
492,01 m
Gain or loss from assets sale
221,50 k
221,50 k
-
-
AI content may include mistakes. Learn more
Google-programme